News about Safety

Safety | 23/01/2023 | By Sudeep Soparkar

Safety | 03/01/2023 | By Sudeep Soparkar

Freudenberg accomplishes ISO 14001 accreditation for its 11 overall destinations

Freudenberg accomplishes ISO 14001 accreditation for its 11 overall destinations

Freudenberg Medical has accomplished ISO 14001 confirmation for every one of the 11 locales in the United States, Costa Rica, Germany, Ireland, and China. Meaning, all Freudenberg Medical activities overall satisfy the most noteworthy guidelines for ecological administration.

Safety | 13/04/2022 | By Sudeep Soparkar 134

Generic Pradaxa Capsules from Alembic Pharma given tentative approval by the US FDA

Generic Pradaxa Capsules from Alembic Pharma given tentative approval by the US FDA

Alembic Pharmaceuticals Limited has gotten speculative endorsement from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for dabigatran etexilate cases, 75 mg, 110 mg, and 150 mg.

Safety | 08/04/2022 | By Sudeep Soparkar 114

COVID medicines medical devices: parliamentary panel for framing price control regime

COVID medicines medical devices: parliamentary panel for framing price control regime

A Parliamentary panel has recommended framing a new price control regime specific for medicines and medical devices for COVID-19 management and put them under price control with no annual increase in prices allowed till the pandemic is entirely over in the country

Safety | 22/03/2022 | By Darshana 154

A Synopsis Of Themis Medicare Viralex

A Synopsis Of Themis Medicare Viralex

Mumbai-based pharmaceutical company Themis Medicare?s anti-viral drug Viralex has received Drugs Controller General of India?s (DCGI) approval, the company informed the stock exchange on Monday

Safety | 21/03/2022 | By Darshana 158

Second R&D Center Of Boston Scientific Corporation Inaugurated In Pune

Second R&D Center Of Boston Scientific Corporation Inaugurated In Pune

The second Research and Development Center is launched by the Boston Scientific Corporation in Pune. The major goal of this move is to make capital out of India?s expertise in R&D and to provide manifold opportunities for engineers and front-runners in the country

Safety | 16/03/2022 | By Darshana 108

First reference lab in Kolkata launched by Lupin

First reference lab in Kolkata launched by Lupin

The new Reference Laboratory at Kolkata has capabilities to conduct a broad spectrum of routine and specialized tests in the fields of molecular diagnostics, cytogenetics, flow cytometry, histopathology, cytology, microbiology, serology, haematology, immunology and routine biochemistry

Safety | 11/03/2022 | By Darshana 112

National Pharmaceutical Pricing Authority fixes price for Intas Pharma's incremental immunoglobulin solution

National Pharmaceutical Pricing Authority fixes price for Intas Pharma's incremental immunoglobulin solution

The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of Intas Pharmaceuticals immunising agent immunoglobulin combination at 15 per cent higher than the existing human normal immunoglobulin solution for infusion 5%, since it is an incremental innovation having advantage without any increased side effect

Safety | 08/03/2022 | By Darshana 102

US FDA approval: CTI BioPharma's bone marrow cancer drug

US FDA approval: CTI BioPharma's bone marrow cancer drug

The drug, Vonjo (pacritinib), belongs to a class of anti-inflammatory treatments called JAK inhibitors, and will compete with Incyte Corp?s Jakafi and Bristol Myers? Inrebic, which were approved in 2011 and 2019 respectively for treating Myelofibrosis

Safety | 04/03/2022 | By Darshana

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology